Cited by 348Cervical Cancer and HPV ResearchVirus-based gene therapy researchCancer-related Molecular Pathways

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Establishment of Human Papillomavirus Infection Requires Cell Cycle Progression

Open access

Pyeon, Dohun, Pearce, Shane M., Lank, Simon M., Ahlquist, Paul, Lambert, Paul F.·2009·PLoS Pathogens

DOI 10.1371/journal.ppat.1000318PMC PMC2642596

Open this paper in CoChat — free account Open PDF

Abstract

Human papillomaviruses (HPVs) are DNA viruses associated with major human cancers. As such there is a strong interest in developing new means, such as vaccines and microbicides, to prevent HPV infections. Developing the latter requires a better understanding of the infectious life cycle of HPVs. The HPV infectious life cycle is closely linked to the differentiation state of the stratified epithelium it infects, with progeny virus only made in the terminally differentiating suprabasal compartment. It has long been recognized that HPV must first establish its infection within the basal layer of stratified epithelium, but why this is the case has not been understood. In part this restriction might reflect specificity of expression of entry receptors. However, this hypothesis could not fully explain the differentiation restriction of HPV infection, since many cell types can be infected with HPVs in monolayer cell culture. Here, we used chemical biology approaches to reveal that cell cycle progression through mitosis is critical for HPV infection. Using infectious HPV16 particles containing the intact viral genome, G1-synchronized human keratinocytes as hosts, and early viral gene expression as a readout for infection, we learned that the recipient cell must enter M phase (mitosis) for HPV infection to take place. Late M phase inhibitors had no effect on infection, whereas G1, S, G2, and early M phase cell cycle inhibitors efficiently prevented infection. We conclude that host cells need to pass through early prophase for successful onset of transcription of the HPV encapsidated genes. These findings provide one reason why HPVs initially establish infections in the basal compartment of stratified epithelia. Only this compartment of the epithelium contains cells progressing through the cell cycle, and therefore it is only in these cells that HPVs can establish their infection. By defining a major condition for cell susceptibility to HPV infection, these results also have potentially important implications for HPV control.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1000318

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Primer3 on the WWW for General Users and for Biologist Programmers
Rozen, S., & Skaletsky, H. (2003) · Humana Press eBooks · doi:10.1385/1-59259-192-2:365 · Cited by 15,068
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., & Fusenig, N. E. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.3.761 · Cited by 4,170
Papillomaviruses and cancer: from basic studies to clinical application
Hausen, H. Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc798 · Cited by 4,031
Human papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen
Mayer, T. U., Kapoor, T. M., Haggarty, S. J., King, R. W., Schreiber, S. L., & Mitchison, T. J. (1999) · Science · doi:10.1126/science.286.5441.971 · Cited by 1,752
Papillomavirus infections — a major cause of human cancers
Hausen, H. Z. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00020-0 · Cited by 1,532
Cdk1 is sufficient to drive the mammalian cell cycle
Santamarı́a, D., Barrière, C., Cerqueira, A., Hunt, S. L., Tardy, C., Newton, K., Cáceres, J. F., Dubus, P. R., Malumbres, M., & Barbacid, M. (2007) · Nature · doi:10.1038/nature06046 · Cited by 1,096
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies
Bernardi, R., & Pandolfi, P. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2277 · Cited by 876
Exploiting Chemical Libraries, Structure, and Genomics in the Search for Kinase Inhibitors
Gray, N. S., Wodicka, L. M., Thunnissen, A. M. W. H., Norman, T., Kwon, S., Espinoza, F. H., Morgan, D. O., Barnes, G., Leclerc, S., Meijer, L., et al. (1998) · Science · doi:10.1126/science.281.5376.533 · Cited by 808
Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus
Lewis, P. F., & Emerman, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.510-516.1994 · Cited by 797

Flagged first, then by citations

Show all 52 references

Sorted by citations

Items 101–200 of 348

Host-cell factors involved in papillomavirus entry
Florin, L., Sapp, M. J., & Spoden, G. A. (2012) · Medical Microbiology and Immunology · doi:10.1007/s00430-012-0270-1 · Cited by 45
Host cell restriction factors that limit transcription and replication of human papillomavirus
Porter, S. S., Stepp, W. H., Stamos, J. D., & McBride, A. A. (2016) · Virus Research · doi:10.1016/j.virusres.2016.11.014 · Cited by 47
Brd4 Activates Early Viral Transcription upon Human Papillomavirus 18 Infection of Primary Keratinocytes
McKinney, C. C., Kim, M. J., Chen, D., & McBride, A. A. (2016) · mBio · doi:10.1128/mbio.01644-16 · Cited by 45
Genome-wide association study of cervical cancer suggests a role for ARRDC3 gene in human papillomavirus infection
Takeuchi, F., Kukimoto, I., Li, Z., Li, S., Li, N., Hu, Z., Takahashi, A., Inoue, S., Yokoi, S., Chen, J., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy390 · Cited by 48
The Papillomavirus Virion: A Machine Built to Hide Molecular Achilles’ Heels
Buck, C. B., & Trus, B. L. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0980-9_18 · Cited by 48
HPV-related oropharyngeal cancers: From pathogenesis to new therapeutic approaches
Tornesello, M. L., Perri, F., Buonaguro, L., Ionna, F., Buonaguro, L., & Caponigro, F. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.06.003 · Cited by 47
PML nuclear body-residing proteins sequentially associate with HPV genome after infectious nuclear delivery
Guion, L. G. M., Bienkowska‐Haba, M., DiGiuseppe, S., Florin, L., & Sapp, M. J. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007590 · Cited by 44
High Human Papillomavirus DNA loads in Inflammatory Middle Ear Diseases
Malagutti, N., Rotondo, J. C., Cerritelli, L., Melchiorri, C., Mattei, M. D., Selvatici, R., Oton, L., Stomeo, F., Mazzoli, M., Borin, M., et al. (2020) · Pathogens · doi:10.3390/pathogens9030224 · Cited by 44
Papillomaviruses and Endocytic Trafficking
Siddiqa, A., Broniarczyk, J. K., & Banks, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092619 · Cited by 43
Inhibition of nuclear entry of HPV16 pseudovirus-packaged DNA by an anti-HPV16 L2 neutralizing antibody
Ishii, Y., Tanaka, K., Kondo, K., Takeuchi, T., Mori, S., & Kanda, T. (2010) · Virology · doi:10.1016/j.virol.2010.07.019 · Cited by 42
Regulation of the Innate Immune Response during the Human Papillomavirus Life Cycle
Moody, C. A. (2022) · Viruses · doi:10.3390/v14081797 · Cited by 47
Human Papillomavirus 16 Capsids Mediate Nuclear Entry during Infection
Day, P. M., Weisberg, A. S., Thompson, C. D., Hughes, M. M., Pang, Y. Y., Lowy, D. R., & Schiller, J. T. (2019) · Journal of Virology · doi:10.1128/jvi.00454-19 · Cited by 42
Skin Viral Infections: Host Antiviral Innate Immunity and Viral Immune Evasion
Lei, V., Petty, A. J., Atwater, A. R., Wolfe, S. A., & MacLeod, A. S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.593901 · Cited by 45
Factors in Oncogenesis: Viral Infections in Ovarian Cancer
Pathak, S., Wilczyński, J. R., & Paradowska, E. (2020) · Cancers · doi:10.3390/cancers12030561 · Cited by 40
Immune responses to human papillomavirus infection and vaccination
Kiamba, E. W., Goodier, M. R., & Clarke, E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1591297 · Cited by 46
Prevention of cancer by prophylactic human papillomavirus vaccines
Kwak, K., Yemelyanova, A. V., & Roden, R. B. S. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.11.009 · Cited by 38
Human papillomavirus infection requires the TSG101 component of the ESCRT machinery
Broniarczyk, J. K., Bergant, M., Goździcka‐Józefiak, A., & Banks, L. (2014) · Virology · doi:10.1016/j.virol.2014.05.005 · Cited by 38
Papillomavirus Infectious Pathways: A Comparison of Systems
Biryukov, J., & Meyers, C. (2015) · Viruses · doi:10.3390/v7082823 · Cited by 40
Roles of vaginal flora in human papillomavirus infection, virus persistence and clearance
Mi, Z., Li, X., Jiao, X., Cai, X., Yao, F., Xu, S., Huang, X., Zhang, Q., & Chen, J. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1036869 · Cited by 38
Human papillomavirus and cervical cancer in the microbial world: exploring the vaginal microecology
Zhang, Z., Ma, Q., Zhang, L., Ma, L., Wang, D., Yang, Y., Jia, P., Wu, Y. F., & Wang, F. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1325500 · Cited by 46
HPV infection and p16 expression in carcinomas of the minor salivary glands
Brunner, M., Koperek, O., Wrba, F., Erović, B. M., Heiduschka, G., Schopper, C., & Thurnher, D. (2011) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-011-1894-2 · Cited by 35
Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism
Day, P. M., Thompson, C. D., Lowy, D. R., & Schiller, J. T. (2017) · Journal of Virology · doi:10.1128/jvi.00168-17 · Cited by 37
Upregulation of stem cell markers ALDH1A1 and OCT4 as potential biomarkers for the early detection of cervical carcinoma
Tulake, W., Yuemaier, R., Sheng, L., Ru, M.-F., Lidifu, D., & Abudula, A. (2018) · Oncology Letters · doi:10.3892/ol.2018.9381 · Cited by 35
Detecting episomal or integrated human papillomavirus 16 DNA using an exonuclease V-qPCR-based assay
Myers, J. E., Guidry, J. T., Scott, M. L., Zwolińska, K., Raikhy, G., Prasai, K., Bienkowska‐Haba, M., Bodily, J. M., Sapp, M. J., & Scott, R. S. (2019) · Virology · doi:10.1016/j.virol.2019.08.021 · Cited by 35
Principles of epithelial homeostasis control during persistent human papillomavirus infection and its deregulation at the cervical transformation zone
Doorbar, J., Zheng, K., Aiyenuro, A. E., Yin, W., Walker, C. M., Chen, Y., Egawa, N., & Griffin, H. M. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.09.014 · Cited by 35
HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers
Manzo-Merino, J., Thomas, M., Fuentes-González, A. M., Lizano, M., & Banks, L. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.832204 · Cited by 35
Human Papillomavirus Infections: Warts or Cancer?Preprint
Chow, L. T., & Broker, T. R. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012997 · Cited by 35
Human Papillomavirus Species-Specific Interaction with the Basement Membrane-Resident Non-Heparan Sulfate Receptor
Richards, K. F., Mukherjee, S., Bienkowska‐Haba, M., Pang, J., & Sapp, M. J. (2014) · Viruses · doi:10.3390/v6124856 · Cited by 34
Human Papillomavirus (HPV) virion induced cancer and subfertility, two sides of the same coin.
Depuydt, C., Beert, J., Bosmans, E., & Salembier, G. M. (2016) · Europe PMC (PubMed Central) · Cited by 34
The role of inflammation in HPV infection of the Oesophagus
Schäfer, G., Kabanda, S. M., van Rooyen, B., Bergant, M., Banks, L., & Parker, M. I. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-185 · Cited by 33
Journey to the Center of the Cell: Current Nanocarrier Design Strategies Targeting Biopharmaceuticals to the Cytoplasm and Nucleus
Munsell, E. V., Ross, N. L., & Sullivan, M. O. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151216151420 · Cited by 35
How SARS-CoV-2 and Other Viruses Build an Invasion Route to Hijack the Host Nucleocytoplasmic Trafficking System
Sajidah, E. S., Lim, K., & Wong, R. W.-C. (2021) · Cells · doi:10.3390/cells10061424 · Cited by 33
HPV31 and HPV33 incidence in cervical samples from women in Recife, Brazil
da Silva, M. F. P. T. B., Chagas, B. S., Guimares, V., Katz, L., Felix, P. M., de Miranda, P. M., Lima, A. A., Arraes, L. C., Martins, D. B. G., Filho, J. L. L., et al. (2009) · Genetics and Molecular Research · doi:10.4238/vol8-4gmr677 · Cited by 32
High incidence of female reproductive tract cancers in FA-deficient HPV16-transgenic mice correlates with E7’s induction of DNA damage response, an activity mediated by E7’s inactivation of pocket proteins
Park, J. W., Shin, M.-K., & Lambert, P. F. (2013) · Oncogene · doi:10.1038/onc.2013.327 · Cited by 31
The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis
Wüstenhagen, E., Hampe, L., Boukhallouk, F., Schneider, M. A., Spoden, G. A., Negwer, I., Koynov, K., Kast, W. M., & Florin, L. (2016) · Journal of Virology · doi:10.1128/jvi.01222-16 · Cited by 31
Strength in Diversity: Nuclear Export of Viral RNAs
Gales, J. P., Kubina, J., Geldreich, A., & Dimitrova, M. (2020) · Viruses · doi:10.3390/v12091014 · Cited by 31
Human Papillomavirus Entry: Hiding in a Bubble
DiGiuseppe, S., Bienkowska‐Haba, M., & Sapp, M. J. (2016) · Journal of Virology · doi:10.1128/jvi.01065-16 · Cited by 31
The VPS4 component of the ESCRT machinery plays an essential role in HPV infectious entry and capsid disassembly
Broniarczyk, J. K., Pim, D., Massimi, P., Bergant, M., Goździcka‐Józefiak, A., Crump, C. M., & Banks, L. (2017) · Scientific Reports · doi:10.1038/srep45159 · Cited by 30
The Role of Promyelocytic Leukemia Nuclear Bodies During HPV Infection
Guion, L. G. M., & Sapp, M. J. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00035 · Cited by 31
SV40 Hijacks Cellular Transport, Membrane Penetration, and Disassembly Machineries to Promote Infection
Chen, Y.-J., Liu, X., & Tsai, B. (2019) · Viruses · doi:10.3390/v11100917 · Cited by 30
A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity
Patra, U., & Müller, S. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.696234 · Cited by 31
Phthalocyanine and Its Formulations: A Promising Photosensitizer for Cervical Cancer Phototherapy
Carobeli, L. R., Meirelles, L. E. D. F., Damke, G. M. Z. F., Damke, E., de Souza, M. V. F., Mari, N. L., Mashiba, K. H., Mesquita, C. S. S., Souza, R. P., da Silva, V. R. S., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122057 · Cited by 31
Cervicovaginal Microbiota Profiles in Precancerous Lesions and Cervical Cancer among Ethiopian Women
Teka, B., Yoshida-Court, K., Firdawoke, E., Chanyalew, Z., Gizaw, M., Addissie, A., Mihret, A., Colbert, L. E., Napravnik, T. C., Alam, M. B. E., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11040833 · Cited by 29
Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma
Cerasuolo, A., Annunziata, C., Tortora, M., Starita, N., Stellato, G., Greggi, S., Maglione, M. G., Ionna, F., Losito, S., Botti, G., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15977 · Cited by 28
Epidermal Growth Factor Receptor and Abl2 Kinase Regulate Distinct Steps of Human Papillomavirus 16 Endocytosis
Bannach, C., Brinkert, P., Kühling, L., Greune, L., Schmidt, M. A., & Schelhaas, M. (2020) · Journal of Virology · doi:10.1128/jvi.02143-19 · Cited by 27
Delta-Like Ligand–Notch1 Signaling Is Selectively Modulated by HPV16 E6 to Promote Squamous Cell Proliferation and Correlates with Cervical Cancer Prognosis
Khelil, M., Griffin, H. M., Bleeker, M. C. G., Steenbergen, R. D. M., Zheng, K., Saunders-Wood, T., Samuels, S., Rotman, J., Vos, W., van den Akker, B. E., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1996 · Cited by 28
Dangerous Liaisons: Long-Term Replication with an Extrachromosomal HPV Genome
Warburton, A., Fera, A. N. D., & McBride, A. A. (2021) · Viruses · doi:10.3390/v13091846 · Cited by 28
Human papillomavirus infection in oral fluids of HIV-1-positive men:prevalence and risk factors
Gaester, K. E. D. O., Fonseca, L. A. M., Luiz, O. D. C., Assone, T., Fontes, A. S., Costa, F. F., Duarte, A. J. S., & Casseb, J. (2014) · Scientific Reports · doi:10.1038/srep06592 · Cited by 28
Inactivation of p53 Rescues the Maintenance of High Risk HPV DNA Genomes Deficient in Expression of E6
Lorenz, L. D., Cardona, J. R., & Lambert, P. F. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003717 · Cited by 28
Repurposing Cardiac Glycosides: Drugs for Heart Failure Surmounting Viruses
Škubník, J., Bejček, J., Pavlíčková, V. S., & Rimpelová, S. (2021) · Molecules · doi:10.3390/molecules26185627 · Cited by 27
High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation
Zheng, Y., Li, X., Jiao, Y., & Wu, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.929666 · Cited by 29
Human Papillomavirus Infectious Entry and Trafficking Is a Rapid Process
Broniarczyk, J. K., Massimi, P., Bergant, M., & Banks, L. (2015) · Journal of Virology · doi:10.1128/jvi.00722-15 · Cited by 27
Incoming human papillomavirus 16 genome is lost in PML protein-deficient HaCaT keratinocytes
Bienkowska‐Haba, M., Łuszczek, W., Keiffer, T. R., Guion, L. G. M., DiGiuseppe, S., Scott, R. S., & Sapp, M. J. (2016) · Cellular Microbiology · doi:10.1111/cmi.12708 · Cited by 27
HPV shapes tumor transcriptome by globally modifying the pool of RNA binding protein-binding motif
Wu, Y. C., Chen, H., Chen, Y., Qu, L., Zhang, E., Wang, Z., Wu, Y., Yang, R., Mao, R., Lu, C., et al. (2019) · Aging · doi:10.18632/aging.101927 · Cited by 26
Emerging Roles of Heparan Sulfate Proteoglycans in Viral Pathogenesis
Koganti, R., Memon, A., & Shukla, D. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1725068 · Cited by 24
HPV16 Entry into Epithelial Cells: Running a Gauntlet
Mikuličić, S., Strunk, J., & Florin, L. (2021) · Viruses · doi:10.3390/v13122460 · Cited by 26
Detection and quantitation of human papillomavirus DNA in peripheral blood mononuclear cells from blood donors
Vergara, N., Balanda, M., Vidal, D., Roldán, F., Martín, H. S., & Ramírez, E., V (2019) · Journal of Medical Virology · doi:10.1002/jmv.25551 · Cited by 25
Electron microscopic visualization of autophagosomes induced by infection of human papillomavirus pseudovirions
Ishii, Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.130 · Cited by 25
DNA-tumor virus entry—From plasma membrane to the nucleus
Püntener, D., & Greber, U. F. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.03.014 · Cited by 25
Viral Genome Tethering to Host Cell Chromatin: Cause and Consequences
Aydin, I., & Schelhaas, M. (2016) · Traffic · doi:10.1111/tra.12378 · Cited by 24
Beneficial effects of a Coriolus versicolor-based vaginal gel on cervical epithelization, vaginal microbiota and vaginal health: a pilot study in asymptomatic women
Palacios, S., Losa, F., Dexeus, D., & Cortés, J. (2017) · BMC Women s Health · doi:10.1186/s12905-017-0374-2 · Cited by 26
HPV-Based Screening, Triage, Treatment, and Followup Strategies in the Management of Cervical Intraepithelial Neoplasia
Peralta-Zaragoza, Ó., Deas, J., Gómez-Cerón, C., García-Suástegui, W. A., Fierros-Zárate, G. D. S., & Jacobo-Herrera, N. J. (2013) · Obstetrics and Gynecology International · doi:10.1155/2013/912780 · Cited by 24
The Known and Potential Intersections of Rab-GTPases in Human Papillomavirus Infections
Young, J. M., Abidine, A. Z. E., Gómez-Martinez, R. A., & Ozbun, M. A. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00139 · Cited by 21
Therapeutic Vaccines for HPV-Associated Oropharyngeal and Cervical Cancer: The Next De-Intensification Strategy?
Morand, G. B., Cardona, I., Cruz, S. B. S. C., Mlynarek, A., Hier, M., Alaoui‐Jamali, M. A., & da Silva, S. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158395 · Cited by 25
Activation of Src, Fyn and Yes non-receptor tyrosine kinases in keratinocytes expressing human papillomavirus (HPV) type 16 E7 oncoprotein
Szalmás, A., Gyöngyösi, E., Ferenczi, A., László, B., Karosi, T., Csomor, P., Gergely, L., Veress, G., & Kónya, J. (2013) · Virology Journal · doi:10.1186/1743-422x-10-79 · Cited by 22
Advances in Targeting HPV Infection as Potential Alternative Prophylactic Means
Carse, S., Bergant, M., & Schäfer, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042201 · Cited by 21
Comprehensive multiomic characterization of human papillomavirus-driven recurrent respiratory papillomatosis reveals distinct molecular subtypes
Sievers, C. M., Robbins, Y. L., Bai, K., Yang, X., Clavijo, P. E., Friedman, J., Sinkoe, A. L., Norberg, S. M., Hinrichs, C. S., Waes, C. V., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02942-0 · Cited by 21
EBV Association with Lymphomas and Carcinomas in the Oral Compartment
Ward, B. H., Schaal, D. L., Nkadi, E. H., & Scott, R. S. (2022) · Viruses · doi:10.3390/v14122700 · Cited by 21
Potential Role of E4 Protein in Human Papillomavirus Screening: a Review
Yajid, A. I., Zakariah, M. A., Zin, A. A. M., & Othman, N. H. (2017) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2017.18.2.315 · Cited by 21
A Ran-binding protein facilitates nuclear import of human papillomavirus type 16
Lai, K.-Y., Rizzato, M., Aydin, I., Villalonga-Planells, R., Drexler, H. C. A., & Schelhaas, M. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009580 · Cited by 23
TNF-α −308 G/A as a Risk Marker of Cervical Cancer Progression in the Polish Population
Roszak, A., Misztal, M., Sowińska, A., & Jagodziński, P. P. (2015) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-015-0130-y · Cited by 20
Autophagy knocked down by high-risk HPV infection and uterine cervical carcinogenesis.
Li, X., Gong, Z., Zhang, L., Zhao, C., Zhao, X., Gu, X., & Chen, H. (2015) · PubMed · Cited by 20
Expression of Yin Yang 1 in cervical cancer and its correlation with E-cadherin expression and HPV16 E6
Wang, W., Yue, Z., Tian, Z., Xie, Y., Zhang, J., She, Y., Yang, B., Yuan, Y., & Yang, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193340 · Cited by 20
Current strategies against persistent human papillomavirus infection (Review)
Liu, Y., Li, H., Pi, R., Yang, Y., Zhao, X., & Qi, X. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4847 · Cited by 23
HPV-assoziierte Plattenepithelkarzinogenese
Assmann, G., & Sotlar, K. (2011) · Der Pathologe · doi:10.1007/s00292-011-1442-2 · Cited by 20
Human Papillomavirus 16 Infection Induces VAP-Dependent Endosomal Tubulation
Siddiqa, A., Massimi, P., Pim, D., Broniarczyk, J. K., & Banks, L. (2018) · Journal of Virology · doi:10.1128/jvi.01514-17 · Cited by 19
Combinational Use of Phytochemicals and Chemotherapeutic Drugs Enhance Their Therapeutic Potential on Human Cervical Cancer Cells
Sundaram, M. K., Raina, R., Afroze, N., Dhupkar, A., Kaur, N. P., Arte, A., Khan, F. A., & Hussain, A. (2019) · International Journal of Cancer Management · doi:10.5812/ijcm.91783 · Cited by 19
A Novel Model for Papillomavirus-Mediated Anal Disease and Cancer Using the Mouse Papillomavirus
Blaine‐Sauer, S., Shin, M.-K., Matkowskyj, K. A., Ward-Shaw, E. T., & Lambert, P. F. (2021) · mBio · doi:10.1128/mbio.01611-21 · Cited by 19
Human Papillomavirus: Biology and Pathogenesis
Verssimo, J., & Fernandes, T. A. A. D. M. (2012) · InTech eBooks · doi:10.5772/27154 · Cited by 22
Recent advances in HPV biotechnology: understanding host-virus interactions and cancer progression – a review
Yousaf, S., Shehzadi, A., Ahmad, M. M., Ahmad, A., Ahmed, I., Iqbal, H. M. N., & Bule, M. H. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000002117 · Cited by 17
HPV induced R-loop formation represses innate immune gene expression while activating DNA damage repair pathways
Templeton, C. W., & Laimins, L. A. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012454 · Cited by 18
Master mitotic kinases regulate viral genome delivery during papillomavirus cell entry
Rizzato, M., Mao, F., Chardon, F., Lai, K.-Y., Villalonga-Planells, R., Drexler, H. C. A., Pesenti, M. E., Fiskin, M., Roos, N., King, K. M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35874-w · Cited by 17
The Cytoskeleton in Papillomavirus Infection
Bienkowska‐Haba, M., & Sapp, M. J. (2011) · Viruses · doi:10.3390/v3030260 · Cited by 17
A Dual Role for the Nonreceptor Tyrosine Kinase Pyk2 during the Intracellular Trafficking of Human Papillomavirus 16
Gottschalk, E. Y., & Meneses, P. I. (2015) · Journal of Virology · doi:10.1128/jvi.01183-15 · Cited by 17
Glycan-induced structural activation softens the human papillomavirus capsid for entry through reduction of intercapsomere flexibility
Feng, Y., van Bodegraven, D., Kádek, A., Munguira, I. L. B., Soria-Martínez, L., Nentwich, S., Saha, S., Chardon, F., Kavan, D., Uetrecht, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54373-0 · Cited by 16
MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers
Wang, Y., Wang, J., & Huang, Y. (2015) · Cancer Biomarkers · doi:10.3233/cbm-150464 · Cited by 16
Orphan Nuclear Receptor PNR/NR2E3 Stimulates p53 Functions by Enhancing p53 Acetylation
Wen, Z. H., Pyeon, D., Wang, Y., Lambert, P. F., Xu, W., & Ahlquist, P. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05513-11 · Cited by 16
Cervical neoplasia–related factors and decreased prevalence of uterine fibroids among a cohort of African American women
Moore, K. R., Smith, J. S., Laughlin-Tommaso, S. K., & Baird, D. D. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.09.021 · Cited by 16
Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry
Broniarczyk, J. K., Massimi, P., Pim, D., Bergant, M., Myers, M. P., Garcea, R. L., & Banks, L. (2019) · Journal of Virology · doi:10.1128/jvi.00128-19 · Cited by 16
The Underlying Mechanism of 3-Hydroxyphthalic Anhydride-Modified Bovine Beta-Lactoglobulin to Block Human Papillomavirus Entry Into the Host Cell
Hua, C., Zhu, Y., Wu, C., Si, L., Wang, Q., Sui, L., & Jiang, S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02188 · Cited by 16
Recent Advances in Our Understanding of the Infectious Entry Pathway of Human Papillomavirus Type 16
Keiffer, T. R., Soorya, S., & Sapp, M. J. (2021) · Microorganisms · doi:10.3390/microorganisms9102076 · Cited by 16
Pathogenesis of Infection by Human Papillomavirus
Brendle, S. A., Bywaters, S. M., & Christensen, N. D. (2014) · Current problems in dermatology · doi:10.1159/000355963 · Cited by 17
The human papillomavirus 16 E5 gene potentiates MmuPV1-Dependent pathogenesis
Torres, A. D., Spurgeon, M. E., Bilger, A., Blaine‐Sauer, S., Uberoi, A., Buehler, D. G., McGregor, S. M., Ward-Shaw, E. T., & Lambert, P. F. (2019) · Virology · doi:10.1016/j.virol.2019.12.002 · Cited by 16
The Tumor Suppressor BRCA1/2, Cancer Susceptibility and Genome Instability in Gynecological and Mammary Cancers
Oubaddou, Y., Ali, F. B., Oubaqui, F. E., Qmichou, Z., Bakri, Y., & Hassani, R. A. E. (2023) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2023.24.9.3139 · Cited by 16
How Enhancing Immunity to Low‐Risk HPV Could Cure Recurrent Respiratory Papillomatosis
Bai, K., & Allen, C. T. (2021) · The Laryngoscope · doi:10.1002/lary.29153 · Cited by 15
Human Keratinocyte Cultures in the Investigation of Early Steps of Human Papillomavirus Infection
Griffin, L., Cicchini, L., Xu, T., & Pyeon, D. (2013) · Methods in molecular biology · doi:10.1007/7651_2013_49 · Cited by 15
Characterizing the spatio-temporal role of sorting nexin 17 in human papillomavirus trafficking
Bergant, M., Peternel, Š., Pim, D., Broniarczyk, J. K., & Banks, L. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000734 · Cited by 15
The Role of the Cervicovaginal and Gut Microbiome in Cervical Intraepithelial Neoplasia and Cervical Cancer
Sims, T. T., Colbert, L. E., & Klopp, A. H. (2020) · Journal of Immunotherapy and Precision Oncology · doi:10.36401/jipo-20-17 · Cited by 14
High-Risk Human Papillomavirus Infection in Lung Cancer: Mechanisms and Perspectives
Osorio, J. C., Candia-Escobar, F., Corvalán, A. H., Calaf, G. M., & Aguayo, F. (2022) · Biology · doi:10.3390/biology11121691 · Cited by 17
The cellular endosomal protein stannin inhibits intracellular trafficking of human papillomavirus during virus entry
Lipovsky, A. I., Erden, A., Kanaya, E., Zhang, W., Crite, M., Bradfield, C. J., MacMicking, J. D., DiMaio, D., Schoggins, J. W., & Iwasaki, A. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000954 · Cited by 14

Authors: Pyeon, D., Pearce, S. M., Lank, S. M., Ahlquist, P., & Lambert, P. F.
Affiliations: University of Wisconsin–Madison (US)
Howard Hughes Medical Institute (US)
Corresponding author: Ahlquist, Paul
Lambert, Paul F.
ORCID: Pyeon, Dohun
Pearce, Shane M.
Ahlquist, Paul
Lambert, Paul F.
Venue: PLoS Pathogens
Publisher: Public Library of Science (PLoS)
Published: 2009-02-27
Volume: 5
Issue: 2
Pages: e1000318
ISSN: 1553-7366 (ISSN-L)
1553-7374
DOI: 10.1371/journal.ppat.1000318
PMC: PMC2642596
OpenAlex: W2074766470
Cited by: 348
References: 52
Citations by year: 2026: 14 · 2025: 22 · 2024: 22 · 2023: 17 · 2022: 16 · 2021: 27 · 2020: 19 · 2019: 25 · 2018: 17 · 2017: 25 · 2016: 26 · 2015: 24 · 2014: 20 · 2013: 30 · 2012: 15
FWCI: 9.85
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (unspecified)
Locations: PLoS Pathogens (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Figshare (submittedVersion, cc-by)
Funders: Howard Hughes Medical Institute
University of Wisconsin-Madison
National Institutes of Health (CA022443)
National Cancer Institute (CA022443, P01CA022443)
National Institute of Allergy and Infectious Diseases (R33AI071947, AI071947, R21AI071947)
Topics: Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords: human papillomavirus, HPV16, cell cycle progression, mitosis, stratified epithelium, keratinocytes, G1 phase, viral gene expression, microbicides, HPV vaccine, viral entry receptor
MeSH terms: Antiviral Agents, Cell Cycle, Cell Division, Cell Survival, Cells, Cultured, Etoposide, Humans, Orthomyxoviridae, Prophase, Transcription, Genetic, Virion, Keratinocytes, Gene Expression Regulation, Viral, Aphidicolin, Genome, Viral, Human papillomavirus 16

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Establishment of Human Papillomavirus Infection Requires Cell Cycle Progression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks